Cargando…

Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives

SIMPLE SUMMARY: Subtotal resection of the esophagus with resection of local lymph nodes is the oncological procedure of choice for advanced esophageal cancer. Reconstruction of the intestinal tract is predominantly performed with a gastric tube. Even in specialized centers, this surgical procedure i...

Descripción completa

Detalles Bibliográficos
Autores principales: Schröder, Wolfgang, Gisbertz, Suzanne S., Voeten, Daan M., Gutschow, Christian A., Fuchs, Hans F., van Berge Henegouwen, Mark I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616112/
https://www.ncbi.nlm.nih.gov/pubmed/34830988
http://dx.doi.org/10.3390/cancers13225834
_version_ 1784604269226229760
author Schröder, Wolfgang
Gisbertz, Suzanne S.
Voeten, Daan M.
Gutschow, Christian A.
Fuchs, Hans F.
van Berge Henegouwen, Mark I.
author_facet Schröder, Wolfgang
Gisbertz, Suzanne S.
Voeten, Daan M.
Gutschow, Christian A.
Fuchs, Hans F.
van Berge Henegouwen, Mark I.
author_sort Schröder, Wolfgang
collection PubMed
description SIMPLE SUMMARY: Subtotal resection of the esophagus with resection of local lymph nodes is the oncological procedure of choice for advanced esophageal cancer. Reconstruction of the intestinal tract is predominantly performed with a gastric tube. Even in specialized centers, this surgical procedure is associated with a high complication but low mortality rate. Therefore, clinical research aims to develop peri- and intra-operative strategies to improve the patient related outcome. ABSTRACT: Transthoracic esophagectomy is currently the predominant curative treatment option for resectable esophageal adenocarcinoma. The majority of carcinomas present as locally advanced tumors requiring multimodal strategies with either neoadjuvant chemoradiotherapy or perioperative chemotherapy alone. Minimally invasive, including robotic, techniques are increasingly applied with a broad spectrum of technical variations existing for the oncological resection as well as gastric reconstruction. At the present, intrathoracic esophagogastrostomy is the preferred technique of reconstruction (Ivor Lewis esophagectomy). With standardized surgical procedures, a complete resection of the primary tumor can be achieved in almost 95% of patients. Even in expert centers, postoperative morbidity remains high, with an overall complication rate of 50–60%, whereas 30- and 90-day mortality are reported to be <2% and <6%, respectively. Due to the complexity of transthoracic esophagetomy and its associated morbidity, esophageal surgery is recommended to be performed in specialized centers with an appropriate caseload yet to be defined. In order to reduce postoperative morbidity, the selection of patients, preoperative rehabilitation and postoperative fast-track concepts are feasible strategies of perioperative management. Future directives aim to further centralize esophageal services, to individualize surgical treatment for high-risk patients and to implement intraoperative imaging modalities modifying the oncological extent of resection and facilitating surgical reconstruction.
format Online
Article
Text
id pubmed-8616112
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86161122021-11-26 Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives Schröder, Wolfgang Gisbertz, Suzanne S. Voeten, Daan M. Gutschow, Christian A. Fuchs, Hans F. van Berge Henegouwen, Mark I. Cancers (Basel) Review SIMPLE SUMMARY: Subtotal resection of the esophagus with resection of local lymph nodes is the oncological procedure of choice for advanced esophageal cancer. Reconstruction of the intestinal tract is predominantly performed with a gastric tube. Even in specialized centers, this surgical procedure is associated with a high complication but low mortality rate. Therefore, clinical research aims to develop peri- and intra-operative strategies to improve the patient related outcome. ABSTRACT: Transthoracic esophagectomy is currently the predominant curative treatment option for resectable esophageal adenocarcinoma. The majority of carcinomas present as locally advanced tumors requiring multimodal strategies with either neoadjuvant chemoradiotherapy or perioperative chemotherapy alone. Minimally invasive, including robotic, techniques are increasingly applied with a broad spectrum of technical variations existing for the oncological resection as well as gastric reconstruction. At the present, intrathoracic esophagogastrostomy is the preferred technique of reconstruction (Ivor Lewis esophagectomy). With standardized surgical procedures, a complete resection of the primary tumor can be achieved in almost 95% of patients. Even in expert centers, postoperative morbidity remains high, with an overall complication rate of 50–60%, whereas 30- and 90-day mortality are reported to be <2% and <6%, respectively. Due to the complexity of transthoracic esophagetomy and its associated morbidity, esophageal surgery is recommended to be performed in specialized centers with an appropriate caseload yet to be defined. In order to reduce postoperative morbidity, the selection of patients, preoperative rehabilitation and postoperative fast-track concepts are feasible strategies of perioperative management. Future directives aim to further centralize esophageal services, to individualize surgical treatment for high-risk patients and to implement intraoperative imaging modalities modifying the oncological extent of resection and facilitating surgical reconstruction. MDPI 2021-11-21 /pmc/articles/PMC8616112/ /pubmed/34830988 http://dx.doi.org/10.3390/cancers13225834 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Schröder, Wolfgang
Gisbertz, Suzanne S.
Voeten, Daan M.
Gutschow, Christian A.
Fuchs, Hans F.
van Berge Henegouwen, Mark I.
Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives
title Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives
title_full Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives
title_fullStr Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives
title_full_unstemmed Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives
title_short Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives
title_sort surgical therapy of esophageal adenocarcinoma—current standards and future perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616112/
https://www.ncbi.nlm.nih.gov/pubmed/34830988
http://dx.doi.org/10.3390/cancers13225834
work_keys_str_mv AT schroderwolfgang surgicaltherapyofesophagealadenocarcinomacurrentstandardsandfutureperspectives
AT gisbertzsuzannes surgicaltherapyofesophagealadenocarcinomacurrentstandardsandfutureperspectives
AT voetendaanm surgicaltherapyofesophagealadenocarcinomacurrentstandardsandfutureperspectives
AT gutschowchristiana surgicaltherapyofesophagealadenocarcinomacurrentstandardsandfutureperspectives
AT fuchshansf surgicaltherapyofesophagealadenocarcinomacurrentstandardsandfutureperspectives
AT vanbergehenegouwenmarki surgicaltherapyofesophagealadenocarcinomacurrentstandardsandfutureperspectives